Are mitochondria critical in the pathogenesis of Alzheimer's disease?

Brain Research Reviews

Volumn 49, Issue 3, 2005, Pages 618-632

  Reddy, P Hemachandra ^a   Beal, M Flint ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

In vitro studies; Mitochondria; Mitochondrial gene expression; Mitochondrial mutations; Oxidative damage; Peripheral cells; Sporadic Alzheimer's disease; Transgenic mice

Indexed keywords

BIOLOGICAL MARKER; FREE RADICAL; TAU PROTEIN;

ALZHEIMER DISEASE; APOPTOSIS; BRAIN FUNCTION; CHEMICAL ANALYSIS; DEGENERATIVE DISEASE; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTRON MICROSCOPY; EXTRACHROMOSOMAL INHERITANCE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUNTINGTON CHOREA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LEBER HEREDITARY OPTIC NEUROPATHY; LEIGH DISEASE; MITOCHONDRIAL GENETICS; MITOCHONDRION; NARP SYNDROME; NERVE FIBER TRANSPORT; NONHUMAN; OXIDATIVE STRESS; PARKINSONISM; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; STATISTICAL SIGNIFICANCE; SYNAPTIC MEMBRANE; TRANSGENIC MOUSE; WILSON DISEASE;

ALZHEIMER DISEASE; ANIMALS; HUMANS; MITOCHONDRIA; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; SYNAPSES;

EID: 27544484846     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresrev.2005.03.004     Document Type: Review

References (158)

1. H.K. Anandatheerthavarada, G. Biswas, M.A. Robin, and N.G. Avadhani Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells J. Cell Biol. 161 2003 41 54
2. G. Ali, W. Wasco, X. Cai, P. Szabo, K.F. Sheu, A.J. Cooper, S.M. Gaston, J.F. Gusella, R.E. Tanzi, and J.P. Blass Isolation, characterization, and mapping of gene encoding dihyrolipoylsuccinyltransferase (E2k) of human alpha-etoglutarate dehydrogenase complex Somatic Cell Mol. Genet. 120 1994 99 105
3. G. Aliev, D. Seyidova, B.T. Lamb, M.E. Obrenovich, S.L. Siedlak, H.V. Vinters, R.P. Friedland, J.C. LaManna, M.A. Smith, and G. Perry Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice Neurol. Res. 25 2003 665 674
4. V. Askanas, J. McFerrin, S. Baque, R.B. Alvarez, E. Sarkozi, and W.K. Engel Transfer of beta-amyloid Precursor protein gene using adenovirus vector causes mitochondrial abnormalities in cultured normal human muscle Proc. Natl. Acad. Sci. U. S. A. 93 1996 1314 1319
5. M.F. Beal Mitochondrial dysfunction in neurodegenerative diseases Biochim. Biophys. Acta 1366 1998 211 213
6. M.F. Beal, and R.F. Ferrante Experimental therapeutics in transgenic mouse models of Huntington's disease Nat. Rev., Neurosci. 5 2004 373 384
7. C. Behl Amyloid beta-protein toxicity and oxidative stress in Alzheimer's disease Cell. Tissue. Res. 290 1997 471 480
8. V. Blanchard, S. Moussaoui, C. Czech, N. Touchet, B. Bonici, M. Planche, T. Canton, I. Jedidi, M. Gohin, O. Wirths, T.A. Bayer, D. Langui, C. Duyckaerts, G. Tremp, and L. Pradier Time sequence of maturation of dystrophic neurites associated with Abeta deposits in APP/PS1 transgenic mice Exp. Neurol. 184 1997 247 263
9. J.P. Blass Metabolic alterations common to neural and non-neural cells in Alzheimer's disease Hippocampus 3 1993 45 54
10. J.P. Blass Cerebral metabolic impairments Z.S. Khachuaturian T.S. Radebaugh Alzheimer's Disease: Cause(s), Diagnosis, Treatment, and Care 1997 CRC Press NY 187 206
11. J.P. Blass Brain metabolism and brain disease: is metabolic deficiency the proximate cause of Alzheimer dementia? J. Neurosci. Res. 66 2001 851 856
12. J.P. Blass, and G.E. Gibson The role of oxidative abnormalities in the pathophysiology of Alzheimer's disease Rev. Neurol. 147 1991 513 525
13. F. Bosetti, F. Brizzi, S. Barogi, M. Mancuso, G. Siciliano, E.A. Tendi, L. Murri, S.I. Rapoport, and G. Solaini Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease Neurobiol. Aging 23 2002 371 376
14. E. Bossy-Wetzel, D.D. Newmeyer, and D.R. Green Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization EMBO J. 17 1998 37 49
15. A.C. Bowling, and M.F. Beal Bioenergetic and oxidative stress in neurodegenerative diseases Life Sci. 56 1995 1151 1171
16. K. Brockmann, A. Bjornstad, P. Dechent, C.G. Korenke, J. Smeitink, J.M. Trijbels, S. Athanassopoulos, R. Villagran, O.H. Skjeldal, E. Wilichowski, J. Frahm, and F. Hanefeld Succinate in dystrophic white matter: a proton magnetic resonance spectroscopy finding characteristic for complex II deficiency Ann. Neurol. 52 2002 38 46
17. M.D. Brown, A.S. Voljavec, M.T. Lott, A. Torroni, C.C. Yang, and D.C. Wallace Mitochondrial DNA complex I and III mutations associated with Leber's hereditary optic neuropathy Genetics 130 1992 163 173
18. M.D. Brown, J.N. Shoffner, Y.L. Kim, A.S. Jun, B.H. Graham, M.F. Cabell, D.S. Gurley, and D.C. Wallace Mitochondrial DNA sequence analysis of four Alzheimer's and Parkinson's disease patients Am. J. Med. Genet. 61 1996 283 289
19. S.E. Browne, A.C. Bowling, M.J. Baik, M. Gurney, R.H. Brown Jr., and M.F. Beal Metabolic dysfunction in familial, but not sporadic, amyotrophic lateral sclerosis J. Neurochem. 71 1998 281 287
20. J. Busciglio, A. Pelsman, C. Wong, G. Pigino, M. Yuan, H. Mori, and B.A. Yankner Altered metabolism of the amyloid beta precursor protein is associated with mitochondrial dysfunction in Down's syndrome Neuron 33 2002 677 688
21. D.A. Butterfield, J. Drake, C. Pocernich, and A. Castegna Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide Trends Mol. Med. 7 2001 548 554
22. R.F. Butterworth, and A.M. Besnard Thiamine-dependent enzyme changes in temporal cortex of patients with Alzheimer's disease Metab. Brain Dis. 5 1995 179 184
23. S.M. Cardoso, I. Santana, R.H. Swerdlow, and C.R. Oliveira Mitochondrial dysfunction of Alzheimer's disease cybrids enhances Abeta toxicity J. Neurochem. 89 2004 1417 1426
24. C.S. Casley, L. Canevari, J.M. Land, J.B. Clark, and M.A. Sharpe Beta-amyloid inhibits integrated mitochondrial respiration and key enzyme activities J. Neurochem. 80 2002 89 100
25. G. Casari, M. De Fusco, S. Ciarmatori, M. Zeviani, M. Mora, P. Fernandez, G. De Michele, A. Filla, S. Cocozza, R. Marconi, A. Durr, B. Fontaine, and A. Ballabio Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease Cell 93 1998 973 983
26. L. Cavelier, I. Erikson, M. Tammi, P. Jalonen, E. Lindholm, E. Jazin, P. Smith, H. Luthman, and U. Gyllensten MtDNA mutations in maternally inherited diabetes: presence of the 3397 ND1 mutation previously associated with Alzheimer's and Parkinson's disease Hereditas 135 2001 65 70
27. K. Chandrasekaran, T. Giordano, D.R. Brady, J. Stoll, K. Hatanpää, L.S. Martin, and S.I. Rapoport Impairment in gene expression ox oxidative metabolism in vulnerable brain regions in Alzheimer's disease Neurobiol. Aging 14 1994 343 532
28. K. Chandrasekharan, K. Hatanppa, D.R. Brady, and S.I. Rapoport SI Evidence for physiological down-regulation of brain oxidative phosphorylation in Alzheimer's disease Exp. Neurol. 142 1996 80 88
29. K. Chandrasekaran, K. Hatanpää, S.I. Rapoport, and D.R. Brady Decreased expression of nuclear and mitochondrial DNA-encoded genes of oxidative phosphorylation in association neocortex in Alzheimer disease Mol. Brain Res. 44 1997 99 104
30. P. Choi, N. Golts, H. Snyder, M. Chong, L. Petrucelli, J. Hardy, D. Sparkman, E. Cochran, J.M. Lee, and B. Wolozin Co-association of parkin and alpha-synuclein NeuroReport 12 2001 2839 2843
31. K.K. Chung, V.L. Dawson, and T.M. Dawson New insights into Parkinson's disease J. Neurol. 250 Suppl. 3 2003 III15 III24
32. J.P. Cleary, D.M. Walsh, J.J. Hofmeister, G.M. Shankar, M.A. Kuskowski, D.J. Selkoe, and K.H. Ashe Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function Nat. Neurosci. 8 2005 79 84
33. M. Corral-Debrinski, T. Horton, M.T. Lott, J.M. Shoffner, F.M. Beal, and D.C. Wallace Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age Nat. Genet. 2 1992 324 329
34. P.E. Coskun, M.F. Beal, and D.C. Wallace Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication Proc. Natl. Acad. Sci U. S. A. 101 2004 10726 10731
35. P.J. Crouch, R. Blake, J.A. Duce, G.D. Ciccotosto, Q.X. Li, K.J. Barnham, C.C. Curtain, R.A. Cherny, R. Cappai, T. Dyrks, C.L. Masters, and I.A. Trounce Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-beta1-42 J. Neurosci. 25 2005 672 679
36. J.B. Davis Oxidative mechanisms in beta-amyloid cytotoxicity Neurodegeneration 5 1996 441 444
37. S.T. Dekosky, S.W. Scheff, and S.D. Styren Structural correlates of cognition in dementia: quantification and assessment of synapse change Neurodegeneration 5 1999 417 421
38. L. De Meirleir, W. Lissens, C. Benelli, G. Ponsot, I. Desguerre, C. Marsac, D. Rodriguez, J.M. Saudubray, F. Poggi, and I. Liebaers Aberrant splicing of exon 6 in the pyruvate dehydrogenase-E1 alpha mRNA linked to a silent mutation in a large family with Leigh's encephalomyelopathy Pediatr. Res. 36 1994 707 712
39. R. Egensperger, S. Kosel, N.M. Schnopp, P. Mehraein, and M.G. Graeber Association of the mitochondrial tRNA(A4336G) mutation with Alzheimer's and Parkinson's diseases Neuropathol. Appl. Neurobiol. 23 1997 315 321
40. J. Egger, and J. Wilson Mitochondrial inheritance in a mitochondrially mediated disease N. Engl. J. Med. 309 1983 142 146
41. Y. Eguchi, S. Shimizu, and Y. Tsujimoto Intracellular ATP levels determine cell death fate by apoptosis or necrosis Cancer Res. 57 1997 1835 1840
42. H. Elkon, J. Don, E. Melamed, I. Ziv, A. Shirvan, and D. Offen Mutant and wild-type alpha-synuclein interact with mitochondrial cytochrome c oxidase J. Mol. Neurosci. 18 2002 229 238
43. A.L. Famulari, E.R. Marschoff, S.F. Llesuy, S. Kohan, J.A. Serra, R.O. Dominguez, M. Repetto, C. Reides, and E. Sacerdotede Lustig The antioxidant enzymatic blood profile in Alzheimer's and vascular diseases. Their association and a possible assay to differentiate demented subjects and controls J. Neurol. Sci. 141 1996 69 78
44. F. Ferreirinha, A. Quattrini, M. Pirozzi, V. Valsecchi, G. Dina, V. Broccoli, A. Auricchio, F. Piemonte, G. Tozzi, L. Gaeta, G. Casari, A. Ballabio, and E.I. Rugarli Axonal degeneration in paraplegin-deficient mice is associated with abnormal mitochondria and impairment of axonal transport J. Clin. Invest. 113 2004 231 242
45. C.E. Finch, and R.E. Tanzi Genetics of aging Science 278 1997 407 411
46. T. Finkel, and N.J. Holbrook Oxidants, oxidative stress and the biology of ageing Nature 408 2000 239 247
47. G.E. Gibson, K.F. Sheu, and J.P. Blass Abnormalities of mitochondrial enzymes in Alzheimer's disease J. Neural Transm. 105 1998 855 870
48. G.E. Gibson, H. Zhang, K.R. Sheu, and L.C. Park Differential alterations in antioxidant capacity in cells from Alzheimer patients Biochim. Biophys. Acta 150 2000 319 329
49. P.F. Good, P. Werner, A. Hsu, C.W. Olanow, and D.P. Perl Evidence for neuronal oxidative damage in Alzheimer's disease Am. J. Pathol. 149 1996 21 28
50. D.R. Green, and G. Kroemer The pathophysiology of mitochondrial cell death Science 305 2004 626 629
51. D.R. Green, and J.C. Reed Mitochondria and apoptosis Science 281 1998 1309 1312
52. J.J. Hansen, A. Durr, I. Cournu-Rebeix, C. Georgopoulos, D. Ang, M.N. Nielsen, C.S. Davoine, A. Brice, B. Fontaine, N. Gregersen, and P. Bross Hereditary spastic paraplegia SPG13 is associated with a mutation in the gene encoding the mitochondrial chaperonin Hsp60 Am. J. Hum. Genet. 70 2002 1328 1332
53. K. Hirai, G. Aliev, A. Nunomura, H. Fujika, R.L. Russell, C.S. Atwood, A.B. Johnson, Y. Kress, H.V. Vinters, M. Tabaton, S. Shiomohama, A.D. Cash, S.L. Siedlak, P.L.R. Harris, P.K. Jones, R.B. Petersen, G. Perry, and M.A. Smith Mitochondrial abnormalities in Alzheimer's disease J. Neurosci. 21 2001 3017 3023
54. S. Hofmann, U. Rothbauer, N. Muhlenbein, W. Neupert, K.D. Gerbitz, M. Brunner, and M.F. Bauer The C66W mutation in the deafness dystonia peptide 1 (DDP1) affects the formation of functional DDP1.TIM13 complexes in the mitochondrial intermembrane space J. Biol. Chem. 277 2002 23287 23293
55. C. Holmes Genotype and phenotypes in Alzheimer's disease Br. J. Psychiatry 180 2002 131 134
56. I.J. Holt, A.E. Harding, R.K. Petty, and J.A. Morgan-Hughes A new mitochondrial disease associated with mitochondrial DNA heteroplasmy Am. J. Hum. Genet. 46 1990 428 433
57. S. Hoyer Oxidative metabolism deficiencies in brains of patients with Alzheimer's disease Acta Neurol. Scand., Suppl. 165 1996 18 24
58. S. Hoyer Models of Alzheimer's disease: cellular and molecular aspects J. Neural Transm., Suppl. 49 1997 11 21
59. H.M. Huang, H. Zhang, H. Xu, and G.E. Gibson Inhibition of the alpha-ketoglutarate dehydrogenase complex alters mitochondrial function and cellular calcium regulation Biochim. Biophys. Acta 1637 2003 119 126
60. T. Hutchin, and G. Cortopassi A mitochondrial DNA clone is associated with increased risk for Alzheimer disease Proc. Natl. Acad. Sci. U. S. A. 92 1995 6892 6895
61. F.J. Jimenez-Jimenez, F. de Bustos, J.A. Molina, J. Benito-Leon, A. Tallon-Barranco, T. Gassalla, M. Orit-Pareja, F. Guillamon, J.C. Rubio, J. Arenas, and R. Enriquez-de-alamanca Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Alzheimer's disease J. Neural Transm. 104 1997 703 710
62. T. Kato The other forgotten genome: mitochondrial DNA and mental disorders Mol. Psychiatry 6 2001 625 633
63. J.N. Keller, Q. Guo, F.W. Holtsberg, A.J. Bruce-Keller, and M.P. Mattson Increased sensitivity to mitochondrial toxin-induced apoptosis in neural cells expressing mutant presenilin-1 is linked to perturbed calcium homeostasis and enhanced oxyradical production J. Neurosci. 18 1998 4439 4450
64. S.M. Khan, D.S. Cassarino, N.N. Abramova, P.M. Keeney, M.K. Borl, P.A. Trimmer, C.T. Krebs, J.C. Bennett, J.K. Parks, R.H. Swerdlow, W.D. Parker Jr., and J.P. Bennett Jr. Alzheimer's disease cybrids replicate beta-amyloid abnormalities through cell death pathways Ann. Neurol. 48 2000 148 155
65. H.S. Kim, J.H. Lee, J.P. Lee, E.M. Kim, K.A. Chang, C.H. Park, S.J. Jeong, M.C. Wittendorp, J.H. Seo, S.H. Choi, and Y.H. Suh Amyloid beta peptide induces cytochrome c release from isolated mitochondria NeuroReport 13 2002 1989 1993
66. D.M. Kirby, A. Boneh, C.W. Chow, A. Ohtake, M.T. Ryan, D. Thyagarajan, and D.R. Thorburn Low mutant load of mitochondrial DNA G13513A mutation can cause Leigh's disease Ann. Neurol. 54 2003 473 478
67. S.J. Kish, C. Bergeron, A. Rajput, S. Dozic, F. Mastrogiacomo, L.J. Chang, J.M. Wilson, L.M. DiStefano, and J.N. Nobrega Brain cytochrome oxidase in Alzheimer's disease J. Neurochem. 59 1992 776 779
68. I.I. Kruman, W.A. Pedersen, J.E. Springer, and M.P. Mattson ALS-linked Cu/Zn-SOD mutation increases vulnerability of motor neurons to excitotoxicity by a mechanism involving increased oxidative stress and perturbed calcium homeostasis Exp. Neurol. 160 1999 28 39
69. H.J. Lee, S.Y. Shin, C. Choi, Y.H. Lee, and S.J. Lee Formation and removal of alpha-synuclein aggregates in cells exposed to mitochondrial inhibitors J. Biol. Chem. 277 2002 5411 5417
70. Z. Li, K.I. Okamoto, Y. Hayashi, and M. Sheng The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses Cell 119 2004 873 887
71. F.H. Lin, R. Lin, H.M. Wisniewski, Y.W. Hwang, I. Grundke-Iqbal, G. Healy-Louie, and K. Iqbal Detection of point mutations in codon 331 of mitochondrial NADH dehydrogenase subunit 2 in Alzheimer's brains Biochem. Biophys. Res. Commun. 182 1992 238 246
72. M.T. Lin, D.K. Simon, C.H. Ahn, L.M. Kim, and M.F. Beal High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain Hum. Mol. Genet. 11 2002 133 145
73. Q. Liu, M.A. Smith, J. Avila, J. Debernardis, M. Kansal, A. Takeda, X. Zhu, A. Nunomura, K. Honda, P.I. Moreira, C.R. Oliveira, M.S. Santos, S. Shimohama, G. Aliev, J. de la Torre, H.A. Ghanbari, S.L. Siedlak, P.L. Harris, L.M. Sayre, and G. Perry Alzheimer-specific epitopes of tau represent lipid peroxidation-induced conformations Free Radical Biol. Med. 38 2005 746 754
74. M.A. Lovell, W.D. Ehmann, S.M. Butler, and W.R. Markesbery Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease Neurology 45 1995 1594 1601
75. M.A. Lovell, W.D. Ehmann, M.P. Mattson, and W.R. Markesbery Elevated 4-hydroynonenal in ventricular fluids in Alzheimer's disease Neurobiol. Aging 18 1997 457 461
76. M.A. Lovell, C. Xie, and W.R. Markesbery Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease Neurology 51 1998 1562 1566
77. X. Luo, S. Pitkanen, S. Kassovska-Bratinova, B.H. Robinson, and D.C. Lehotay Excessive formation of hydroxyl radicals and aldehydic lipid peroxidation products in cultured skin fibroblasts from patients with complex I deficiency J. Clin. Invest. 99 1997 2877 2882
78. J.W. Lustbader, M. Cirilli, C. Lin, H.W. Xu, K. Takuma, N. Wang, C. Caspersen, X. Chen, S. Pollak, M. Chaney, F. Trinchese, S. Liu, F. Gunn-Moore, L.F. Lue, D.G. Walker, P. Kuppusamy, Z.L. Zewier, O. Arancio, D. Stern, S.S. Yan, and H. Wu ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease Science 304 2004 448 452
79. S. Lutsenko, and M.J. Cooper Localization of the Wilson's disease protein product to mitochondria Proc. Natl. Acad. Sci. U. S. A. 95 1998 6004 6009
80. L. Lyras, N.J. Cairns, A. Jenner, P. Jenner, and B. Halliwell An assessment of oxidative damage to protein, lipids, and DNA in brain from patients with Alzheimer's disease J. Neurochem. 68 1997 2061 2069
81. L. Lyras, R.H. Perry, E.K. Perry, P.G. Ince, P. Jenner, and B. Halliwell Oxidative damage to proteins, lipids, and antioxidant enzyme regions from patients with dementia with Lewy bodies J. Neurochem. 71 1998 302 312
82. M. Manczak, B.S. Park, Y. Jung, and P.H. Reddy Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: implications for early mitochondrial dysfunction and oxidative damage Neuromol. Med. 5 2004 147 162
83. M. Manczak, Y. Jung, B.S. Park, D. Partovi, and P.H. Reddy Time-course of mitochondrial gene expressions in mice brains: implications for mitochondrial dysfunction, oxidative damage, cytochrome c release in aging J. Neurochem. 92 2005 494 504
84. E.M. Mandelkow, K. Stamer, R. Vogel, E. Thies, and E. Mandelkow Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses Neurobiol. Aging 24 2003 1079 1085
85. E.M. Mandelkow, E. Thies, B. Trinczek, J. Biernat, and E. Mandelkow MARK/PAR1 kinase is a regulator of microtubule-dependent transport in axons J. Cell Biol. 167 2004 99 110
86. W.R. Markesbery Oxidative stress hypothesis in Alzheimer's disease Free Radical Biol. Med. 23 1998 134 147
87. W.R. Markesbery The role of oxidative stress in Alzheimer's disease Arch. Neurol. 56 1999 1449 1456
88. W.R. Markesbery, and J.M. Carney Oxidative alterations in Alzheimer's disease Brain Pathol. 9 1999 133 146
89. C.A. Marques, U. Keil, A. Bonert, B. Steiner, C. Haass, W.E. Muller, and A. Eckert Neurotoxic mechanisms caused by the Alzheimer's disease-linked Swedish amyloid precursor protein J. Biol. Chem. 278 2003 28294 28302
90. C. Marsac, C. Benelli, I. Desguerre, M. Diry, F. Fouque, L. De Meirleir, G. Ponsot, S. Seneca, F. Poggi, J.M. Saudubray, M.T. Zabot, D. Fontan, and W. Lissens Biochemical and genetic studies of four patients with pyruvate dehydrogenase E1 alpha deficiency Hum. Genet. 99 2003 785 792
91. F. Mastrogiacomo, C. Bergeron, and S.J. Kish Brain α-ketoglutarate dehydrogenase activity in Alzheimer's disease J. Neurochem. 61 1994 2007 2014
92. M.P. Mattson, J. Parting, and J.G. Begley Amyloid beta-peptide induces apoptosis-related events in synapses and dendrites Brain Res. 807 1998 76 82
93. M.P. Mattson, D.S. Gary, S.L. Chan, and W. Duan Perturbed endoplasmic reticulum function, synaptic apoptosis and the pathogenesis of Alzheimer's disease Biochem. Soc. Symp. 67 2001 151 162
94. P. Mecocci, U. MacGarvey, and M.F. Beal Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease Ann. Neurol. 36 1994 747 751
95. T.J. Montine, W.R. Markesbery, J.D. Morrow, and L.J.N. Roberts Cerebrospinal fluid F2-isopronelevels are increased in Alzheimer's disease Ann. Neurol. 44 1998 410 413
96. K. Nakano, C. Takase, T. Sakamoto, S. Nakagawa, J. Inazawa, S. Ohta, and S. Matuda Isolation, characterization, and structural organization of the gene and pseudogene for the dihyrolipoyl sucinyltransferase component of the human 2-oxoglutarate dehydrogenase complex Eur. J. Biochem. 224 1994 179 189
97. C.W. Olanow An introduction to the free radical hypothesis in Parkinson's disease Ann. Neurol. 32 1992 S2 S9
98. W.D. Parker Jr., C.M. Filley, and J.K. Parks Cytochrome oxidase deficiency in Alzheimer's disease Neurology 40 1990 1302 1303
99. W.D. Parker Jr., J. Parks, C.M. Filley, and B.K. Kleinschmidt-DeMasters Electron transport chain defects in Alzheimer's disease brain Neurology 44 1994 1090 1096
100. P. Pecina, M. Capkova, S.K. Chowdhury, Z. Drahota, A. Dubot, A. Vojtiskova, H. Hansikova, H. Houst'kova, J. Zeman, C. Godinot, and J. Houstek Functional alteration of cytochrome c oxidase by SURF1 mutations in Leigh syndrome Biochim. Biophys. Acta 1639 2003 53 63
101. E.K. Perry, R.H. Perry, B.E. Tomlinson, G. Blessed, and P.H. Gibson Coenzyme A acetylating enzymes in Alzheimer's disease: possible cholinergic 'compartment' of pyruvate dehydrogenase Neurosci. Lett. 18 1998 105 110
102. G. Perry, H. Roder, A. Nunomura, A. Takeda, A.L. Friedlich, X. Zhu, A.K. Raina, N. Holbrook, S.L. Siedlak, P.L. Harris, and M.A. Smith Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation NeuroReport 2 1999 2411 2415
103. V. Petruzzella, G. Di Giacinto, S. Scacco, F. Piemonte, A. Torraco, R. Carrozzo, R. Vergari, C. Dionisi-Vici, D. Longo, A. Tessa, S. Papa, and E. Bertini Atypical Leigh syndrome associated with the D393N mutation in the mitochondrial ND5 subunit Neurology 61 2003 1017 1018
104. S. Pitkanen, and B.H. Robinson Mitochondrial complex I deficiency leads to increased production of superoxide radicals and induction of superoxide dismutase J. Clin. Invest. 98 1996 345 351
105. S. Pitkanen, F. Merante, D.R. McLeod, D. Applegarth, T. Tong, and B.H. Robinson Familial cardiomyopathy with cataracts and lactic acidosis: a defect in complex I (NADH-dehydrogenase) of the mitochondria respiratory chain Pediatr. Res. 39 1996 513 521
106. J. Poirier, J. Davignon, D. Bouthillier, S. Kogan, P. Bertrand, and S. Gauthier Apolipoprotein E polymorphism and Alzheimer's disease Lancet 342 1993 697 699
107. D. Pratico, O.P. Barry, J.A. Lawson, M. Adiyaman, S.W. Hwang, S.P. Khanapure, L. Iuliano, J. Rokach, and G.A. FitzGerald IPF2alpha-I: an index of lipid peroxidation in humans Proc. Natl. Acad. Sci. U. S. A. 95 1998 3449 4454
108. D. Pratico, K. Uryu, S. Leight, J.Q. Trojanowski, and V.M. Lee Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis J. Neurosci. 21 2001 4137 4183
109. H. Puccio, D. Simon, M. Cossee, P. Criqui-Filipe, F. Tiziano, J. Melki, C. Hindelang, R. Matyas, P. Rustin, and M. Koenig Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits Nat. Genet. 27 2001 181 186
110. P.H. Reddy, S. McWeeney, M. Manczak, B.S. Park, R.V. Gutala, Y. Jung, V. Yau, R. Searles, M. Mori, and J. Quinn Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: upregulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease Hum. Mol. Genet. 13 2004 1225 1240
111. P.H. Reddy, G. Mani, B.S. Park, J. Jaques, G. Murdoch, W. Whetsell Jr., J. Kaye, and M. Manczak Differential loss of synaptic proteins in Alzheimer's disease patients: implications to synaptic damage J. Alzheimer's Dis. 7 2005 103 117
112. E.M. Reiman, R.J. Caselli, L.S. Yun, K. Chen, D. Bandy, S. Minoshima, S.N. Thibodeau, and D. Osborne Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E N. Engl. J. Med. 334 1996 752 758
113. J.E. Ricci, C. Munoz-Pinedo, P. Fitzgerald, B. Bailly-Maitre, G.A. Perkins, N. Yadava, I.E. Scheffler, M.H. Ellisman, and D.R. Green Disruption of mitochondrial function during apoptosis is mediated by caspase cleavage of the p75 subunit of complex I of the electron transport chain Cell 117 2004 773 786
114. K. Roesch, P.J. Hynds, R. Varga, L. Tranebjaerg, and C.M. Koehler The calcium-binding aspartate/glutamate carriers, citrin and aralar1, are new substrates for the DDP1/TIMM8a-TIMM13 complex Hum. Mol. Genet. 13 2004 2101 20111
115. A.D. Roses Apolipoprotein E alleles risk factors in Alzheimer's disease Annu. Rev. Med. 47 1996 387 400
116. L.M. Sayree, D.A. Zelasko, P.L. Harris, G. Perry, R.G. Salomon, and M.A. Smith 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease J. Neurochem. 68 1997 2092 2097
117. A.H.V. Schapira, and H.R. Cock Mitochondrial myopathies and encephalomyopathies Eur. J. Clin. Invest. 29 1999 886 898
118. G. Schatz The protein import system of mitochondria J. Biol. Chem. 271 1996 31763 31776
119. D.E. Schmechel, A.M. Saunders, W.J. Strittmatter, B.J. Crain, C.M. Hulette, S.H. Joo, M.A. Perica Vance, D. Goldgaber, and A.D. Roses Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late onset Alzheimer's disease Proc. Natl. Acad. Sci. U. S. A. 90 1993 9649 9653
120. M. Schwartz, and J. Vissing New patterns of inheritance in mitochondrial disease Biochem. Biophys. Res. Commun. 310 2003 247 251
121. D.J. Selkoe Alzheimer's disease: genes, proteins, and therapy Physiol. Rev. 81 2001 741 766
122. J.P. Sheehan, R.W. Swerdlow, S.W. Miller, R.E. Davis, J.K. Parks, W.D. Parker, and J.B. Tuttle Calcium homeostasis and reactive oxygen species production in cells transformed by mitochondria from individuals with sporadic Alzheimer's disease J. Neurosci. 17 1997 4522 4612
123. K.F.R. Sheu, P. Sarkar, W. Wasco, R.E. Tanzi, and J.P. Blass A gene locus of dihyrolipoyl sucinyltransferase (DLST) is associated with Alzheimer's disease J. Neurochem. 66 Suppl. 1 1996 S10
124. K.F.R. Sheu, A. Brown, and J.P. Blass α-Ketoacid dehydrogenase complexes in inborn errors of metabolism and neurodegeneration J. Neurochem. 69 1997 S2
125. K.F.R. Sheu, N.Y. Calingasan, J.G. Lindsay, and G.E. Gibson Immunochemical characterization of the deficiency of the alpha-ketoglutarate dehydrogenase complex in thiamine-deficient rat brain J. Neurochem. 70 1998 1143 1150
126. M.K. Shigenaga, T.M. Hagen, and B.N. Ames Oxidative damage and mitochondrial decay in aging Proc. Natl. Acad. Sci. U. S. A. 91 1994 10771 10778
127. J.M. Shoffner Oxidative phosphorylation defects and Alzheimer's disease Neurogenetics 1 1997 13 19
128. J.M. Shoffner, M.D. Brown, A. Torroni, M.T. Lott, M.F. Cabell, S.S. Mirra, M.F. Beal, C.C. Yang, M. Gearing, and R. Salvo Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients Genomics 17 1993 171 184
129. N.A. Simonian, and B.T. Hyman Functional alterations in Alzheimer's disease: selective loss of mitochondrial-encoded cytochrome oxidase mRNA in the hippocampal formation J. Neuropathol. Exp. Neurol. 53 1994 508 512
130. G.W. Small, J.C. Mazziotta, M.T. Collins, L.R. Baxter, M. Phelps, M.A. Mandelkern, A. Kaplan, A. La Rue, C.F. Adamson, and L. Chang Apolipoprotein E type 4 allele andcerebral glucose metabolism in relatives at risk for familial Alzheimer disease JAMA 273 1995 942 947
131. D.H. Small, S.S. Mok, and J.C. Bornstein Alzheimer's disease and Abeta toxicity: from top to bottom Nat. Rev., Neurosci. 2 2001 595 598
132. C.D. Smith, J.M. Carney, P.E. Starke-Reed, C.N. Oliver, E.R. Stadtman, R.A. Floyd, and W.R. Markesbery Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer's disease Proc. Natl. Acad. Sci. U. S. A. 88 1991 10540 10543
133. M.A. Smith, L.M. Sayre, V.M. Monnier, and G. Perry Oxidative posttranslational modifications in Alzheimer disease. A possible pathogenic role in the formation of senile plaques and neurofibrillary tangles Mol. Chem. Neuropathol. 28 1996 41 48
134. M.A. Smith, K. Hirai, K. Hsiao, M.A. Papolla, P.L. Harris, S.L. Siedlak, M. Tabaton, and G. Perry Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress J. Neurochem. 70 1998 2212 2215
135. M.A. Smith, A. Nunomura, X. Zhu, A. Takeda, and G. Perry Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease Antioxid. Redox Signal 2 2000 413 420
136. M.A. Smith, K.L. Drew, A. Nunomura, A. Takeda, K. Hirai, X. Zhu, C.S. Atwood, A.K. Raina, C.A. Rottkamp, L.M. Sayre, R.P. Friedland, and G. Perry Amyloid-beta, tau alterations and mitochondrial dysfunction in Alzheimer disease: the chickens or the eggs? Neurochem. Int. 40 2002 527 531
137. K. Stamer, R. Vogel, E. Thies, E. Mandelkow, and E.M. Mandelkow Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress J. Cell Biol. 156 2002 1051 1063
138. A.A. Starkov, G. Fiskum, C. Chinopoulos, B.J. Lorenzo, S.E. Browne, M.S. Patel, and M.F. Beal Mitochondrial alpha-ketoglutarate dehydrogenase complex generates reactive oxygen species J. Neurosci. 24 2004 7779 7788
139. C. Strazielle, C. Sturchler-Pierrat, M. Staufenbiel, and R. Lalonde Regional brain cytochrome oxidase activity in beta-amyloid precursor protein transgenic mice with the Swedish mutation Neuroscience 118 2003 1151 1163
140. J.H. Su, A.J. Anderson, D.H. Cribbs, C. Tu, L. Tong, P. Kesslack, and C.W. Cotman Fas and Fas ligand are associated with neuritic degeneration in the AD brain and participate in beta-amyloid-induced neuronal death Neurobiol. Dis. 12 2003 182 193
141. R.H. Swerdlow, and S.M. Khan A "mitochondrial cascade hypothesis" for sporadic Alzheimer's disease Med. Hypotheses 63 2004 8 20
142. R.H. Swerdlow, J.K. Parks, D.S. Cassarino, D.J. Maguire, R.S. Maguire, J.P. Bennett Jr., R.E. Davis, and W.D. Parker Jr. Cybrids in Alzheimer's disease: a cellular model of the disease? Neurology 49 1997 918 925
143. A. Takeda, M.A. Smith, J. Avila, A. Nunomura, S.L. Siedlak, X. Zhu, G. Perry, and L.M. Sayre In Alzheimer's disease, heme oxygenase is coincident with Alz50, an epitope of tau induced by 4-hydroxy-2-nonenal modification J. Neurochem. 75 2000 1234 1241
144. J. Thome, W. Gsell, M. Rosler, J. Komhuber, L. Frolich, E. Hashimoto, B. Zielke, G.A. Wiesbeck, and P. Riederer Oxidative-stress associated parameters (lactoferrin, superoxide dismutases) in serum of patients with Alzheimer's disease Life Sci. 60 1997 13 19
145. R.E. Tanzi, and L. Bertram New frontiers in Alzheimer's disease genetics Neuron 3 2001 181 184
146. R.E. Tanzi, and L. Bertram Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective Cell 120 2005 545 555
147. R.D. Terry, E. Masliah, D.P. Salmon, N. Butters, R. DeTeresa, R. Hil, L.A. Hansen, and R. Katzman Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment Ann. Neurol. 30 1991 572 580
148. P.A. Trimmer, P.M. Keeney, M.K. Borland, F.A. Simon, J. Almeida, R.H. Swerdlow, J.P. Parks, W.D. Parker Jr., and J.P. Bennett Jr. Mitochondrial abnormalities in cybrid cell models of sporadic Alzheimer's disease worsen with passage in culture Neurobiol. Dis. 15 2004 29 39
149. I. Trounce, S. Neill, and D.C. Wallace Cytoplasmic transfer of the mtDNA nt 8993 T-(G (ATP6) point mutation associated with Leigh syndrome into mtDNA-less cells demonstrates cosegregation with a decrease in state III respiration and ADP/O ratio Proc. Natl. Acad. Sci. U. S. A. 91 1994 8334 8338
150. M. Tulinius, A.R. Moslemi, N. Darin, B. Westerberg, L.M. Wiklund, E. Holme, and A. Oldfors Leigh syndrome with cytochrome-c oxidase deficiency and a single T insertion nt 5537 in the mitochondrial tRNATrp gene Neuropediatrics 34 2003 87 91
151. C. Tysoe, D. Robinson, C. Brayne, T. Dening, E.S. Paykel, F.A. Huppert, and D.C. Rubinsztein The tRNA(Gln) 4336 mitochondrial DNA variant is not a high penetrance mutation which predisposes to dementia before the age of 75 years J. Med. Genet. 33 1996 1002 1006
152. R. Van Coster, S. Seneca, J. Smet, R. Van Hecke, E. Gerlo, B. Devreese, J. Van Beeumen, J.G. Leroy, L. De Meirleir, and W. Lissens Homozygous Gly555Glu mutation in the nuclear-encoded 70 kDa flavoprotein gene causes instability of the respiratory chain complex II Am. J. Med. Genet. 120A 2003 13 18
153. C.M. Yates, J. Butterworth, M.C. Tennant, and A. Gordon Enzyme activities in relation to pH and lactate in post-mortem brain in Alzheimer-type and other dementias J. Neurochem. 55 1990 444 449
154. T. Yokota, K. Sugawara, K. Ito, R. Takahashi, H. Ariga, and H. Mizusawa Down regulation of DJ-1 enhances cell death by oxidative stress, ER stress, and proteasome inhibition Biochem. Biophys. Res. Commun. 312 2003 1342 1348
155. D.C. Wallace Mitochondrial diseases in man and mouse Science 283 1999 1482 1488
156. D.M. Walsh, I. Klyubin, J.V. Fadeeva, W.K. Cullen, R. Anwyl, M.S. Wolfe, M.J. Rowan, and D.J. Selkoe Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo Nature 416 2002 535 539
157. N.J. Waterhouse The cellular energy crisis: mitochondria and cell death Med. Sci. Sports Exercise 35 2003 105 110
158. S.L. Williams, J.W. Taanman, H. Hansikova, H. Houst'kova, S. Chowdhury, J. Zeman, and J. Houstek A novel mutation in SURF1 causes skipping of exon 8 in a patient with cytochrome c oxidase-deficient leigh syndrome and hypertrichosis Mol. Genet. Metab. 73 2001 340 343